{"title":"Pathogenesis and treatment of spasticity","authors":"E. Katunina","doi":"10.32756/0869-5490-2021-3-18-24","DOIUrl":null,"url":null,"abstract":"In a review article, the author discusses the mechanisms of spasticity after stroke, its clinical manifestations and approaches to treatment including physical therapy, surgery and the use of central (tolperisone, baclophen and tizanidine) and peripheral (botulinum toxin A) acting muscle relaxants.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2021-3-18-24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
In a review article, the author discusses the mechanisms of spasticity after stroke, its clinical manifestations and approaches to treatment including physical therapy, surgery and the use of central (tolperisone, baclophen and tizanidine) and peripheral (botulinum toxin A) acting muscle relaxants.